Research: Improving participation in colorectal cancer screening

Blue Mars

Research: Improving participation in colorectal cancer screening

As part of the fight against colorectal cancer, a study commissioned by the French National Cancer Institute (INCa) byUnit INSERM 1086 ANTICIPE , and sponsored by the Caen Normandy University Hospital, is currently evaluating the impact of sending screening kits directly to homes. With participation in organized colorectal cancer screening (DOCCR) in France below 40%, this approach aims to improve participation rates by eliminating the need for a medical consultation.

Goals

The EXPEDIT study, sponsored by the Caen Normandy University Hospital and conducted in the Centre-Val de Loire region, involves 64,000 people eligible for the DOCCR (Direct Mailing of the Colonic Ovulation and Reproductive Cancer Screening Program). It aims to specifically examine the influence of direct mailing of the test on participation in screening and the rate of colonoscopy in the event of a positive result, while also evaluating the cost-effectiveness.

Organized colorectal cancer screening is recommended every two years for women and men aged 50 to 74 with no symptoms or medical history. The test can usually be obtained from a doctor (general practitioner, gastroenterologist, gynecologist), a pharmacy, or ordered online.

Assumptions and expectations

The study's fundamental hypothesis is that sending screening kits directly to participants' homes will significantly improve the rate and time to participation in the DOCCR program, while preserving the colonoscopy rate. This approach could also prove economically viable.

This promising study is part of a strategic initiative to increase the effectiveness of colorectal cancer screening in France.